Structure-based design of potent and ligand-efficient inhibitors of CTX-M class A β-lactamase
The emergence of CTX-M class A extended-spectrum β-lactamases poses a serious health threat to the public. We have applied structure-based design to improve the potency of a novel noncovalent tetrazole-containing CTX-M inhibitor (Ki = 21 μM) mo